S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Japan's anti-monopoly body orders Google to fix ad search limits affecting Yahoo

Moolec Science (MLEC) Stock Forecast & Price Target

$1.40
+0.02 (+1.45%)
(As of 04/19/2024 08:51 PM ET)

Moolec Science Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Buy
Based on 3 Analyst Ratings

Analysts' Consensus Price Target

$5.50
292.86% Upside
High Forecast$6.00
Average Forecast$5.50
Low Forecast$5.00
TypeCurrent Forecast
4/23/23 to 4/22/24
1 Month Ago
3/24/23 to 3/23/24
3 Months Ago
1/23/23 to 1/23/24
1 Year Ago
4/23/22 to 4/23/23
Consensus Rating
Buy
Buy
Buy
N/A
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
N/A
Buy
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
N/A
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
N/A
Consensus Price Target$5.50$5.50$5.00N/A
Predicted Upside292.86% Upside119.12% Upside62.34% UpsideN/A
Get Moolec Science Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MLEC and its competitors with MarketBeat's FREE daily newsletter.

MLEC Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MLEC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Moolec Science Stock vs. The Competition

TypeMoolec ScienceConsumer Staples CompaniesS&P 500
Consensus Rating Score
3.00
2.43
2.49
Consensus RatingBuyHoldHold
Predicted Upside292.86% Upside705.55% Upside11.94% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/30/2024Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$6.00+209.28%
9/27/2023Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Wright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
9/27/2023Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$5.00+62.34%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 06:14 AM ET.

MLEC Price Target - Frequently Asked Questions

What is Moolec Science's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Moolec Science stock is Buy based on the current 3 buy ratings for MLEC. The average twelve-month price prediction for Moolec Science is $5.50 with a high price target of $6.00 and a low price target of $5.00. Learn more on MLEC's analyst rating history.

Do Wall Street analysts like Moolec Science more than its competitors?

Analysts like Moolec Science more than other Consumer Staples companies. The consensus rating for Moolec Science is Buy while the average consensus rating for consumer staples companies is Hold. Learn more on how MLEC compares to other companies.

Does Moolec Science's stock price have much upside?

According to analysts, Moolec Science's stock has a predicted upside of 119.12% based on their 12-month stock forecasts.

What analysts cover Moolec Science?

Moolec Science has been rated by Maxim Group in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:MLEC) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners